ScholarLens Back to search
2023•Journal of Thoracic OncologyOpen access

EP11.03-13 Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study

Ruth Álvarez, Enric Carcereny, A. Padilla, José Manuel Rodríguez García, Juan F. Córdoba, Emilio Esteban, Carlos Aguado, J. Garde, Alberto Moreno-Vega, C. Ávila Andrade, María Sereno, Alfredo Sánchez-Hernández, M. López-Brea, Bartomeu Massutí, C. Martí Blanco, Marc Campayo, Pablo Arnáiz, D. Pérez Parente, C.A. Fajardo, Inmaculada Ramos

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Atezolizumab, Medicine, Docetaxel, Oncology, Lung cancer, Internal medicine, Special populations, Nivolumab

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
EP11.03-13 Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study — Research Paper | ScholarLens